Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Management of Parkinson's Disease Psychosis in Actual Practice (The INSYTE Study)

NCT03152292 is registered in ClinicalTrials.gov with ACADIA Pharmaceuticals Inc. as lead sponsor.

NCT NCT03152292
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03152292 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Management of Parkinson's Disease Psychosis in Actual Practice (The INSYTE Study)
Lead sponsor
ACADIA Pharmaceuticals Inc.
Phase
Observational
Overall status
Terminated
Start date
March 30, 2017
Completion date
March 8, 2021
Enrollment
764 (actual)
Sites
69

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson disease psychosis